Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT)
Bands
Volume
200 SMA
50 SMA
20 SMA
Videos
Alerts
Articles
Events
Old Forum Content for ARCT
Make a Forum Post Become a member to view recent forum posts. Already a member? Sign in here.
- woodman: This is a list of #Gene editing/therapy #Car-T stocks (#Biotech subset). I haven't updated it in some time, so it's not an up-to-date/complete list, but it provides a number stocks that are acting very well and, if you've paid any attention to this area over the years, you'll certainly recognize many of them (including $NTLA which @Dan added to his list today). If interested, kick some of their tires over the weekend (listed below in order of performance today). $ABEO $ADVM $EIGR $PGEN $QURE $RARE $AGTC $SRNE $BLUE $PRTA $CLLS $AVRO $MGTX $ADAP $KRYS $SRPT $BMRN $AMGN $ARCT $RGNX $CNCR $SLDB $TCRT $AGIO $NVS $JNJ $PFE $IOVA $NTLA $SGMO $LUMO $EDIT $VYGR $ORTX $CRSP $BLCM $BBIO
- Henry: @Henry $MRNA $ARCT The later reported this am, better than expected, but losing $. They are working on a 3rd stage trial for a single dose covid vax. A TOS new hit at 07:55 am with the title Arcturus Soars, but there was no content in the article about ARCT, at that moment MRNA started to fall
- jpoko13: @Angdionk $SRPT Thanks for the heads up! If it's anything like $ARCT (which is still trying to fill the gap) happier days ahead!
- bRobert: @jpoko13 $SRPT $ARCT I prefer indexes most of the time $XBI $LABU $IBB $BIB Less black swan risk
- jpoko13: $ARCT looking to begin the gap close :)
- bRobert: @jpoko13 $ARCT It is in. $XBI. $LABU. Many high flyers in the space. Gert a bunch under one roof. 50 - 100%. upside. from here Look at the top. holdings in $XBI. VERY. BULLISH WEEKLY CHART
- jpoko13: @bRobert $ARCT $XBI $LABU Oh ok I didn't know that...question for ya, just how many of your stock predictions do you participate in? I mean do you buy ALL the ones you post? Curious
- jpoko13: $ARCT is having an outstanding day! Long since $45
- Margi1983: @jpoko13 $ARCT @Dan@scottrades Talk about a bad trade being made good. I had a limit buy at 54.80 for $ARCT that hit on 12/29/20, the day it crashed from 100 to 40. I felt like an idiot as I was down $14 a share the first minute I owned it. But it was a smallish position so I broke discipline ( sorry @ Dan) and held it "hoping" I could reduce my loss after 2-3 days. ( Another broken promise not to hope?). Now six days later it is up 35% today and I look like a genius. But I am not. This is a great example of bad limit buy trade that worked out. It was a bet on "red" at the casino of biotech that eventually hit and I do not gamble. Long with a stop at 60
- jpoko13: @Margi1983 $ARCT Right! See I just love these dead cat bounces. I stalk the stock after it's great fall from grace. Then buy as it goes up "hoping" it will break the high from the day it fell and then off to the races to fill the gap. One of my favorite side trades I like to do. I'm no genius either but anyone can make that trade!
- jpoko13: $ARCT Dead cat bounce still ALIVE...pb opportunity RHRN
- jpoko13: $ARCT bought this dead cat bounce twice for a cost basis of $45...on the run and looking for it to start to fill the gap
- Sher: $ARCT (RNA therapeutics) - May be worth watching - Got completely crushed, yesterday (post below), following underwhelming results - But 55%?! Schwab Options Update - "Leading both the point and percentage decliners list this morning is Arcturus Therapeutics Holdings Inc. (ARCT - $48.81 to $43.60) after the biopharmaceutical company reported lackluster study data from its COVID-19 vaccine (ARCT-021) last night after the market close. Baird analyst Madhu Kumar called the data “underwhelming” and lowered his rating to “Neutral” from “Outperform” with a price target cut to $69.00 from $79.00. H.C. Wainwright dropped their rating to “Neutral” from “Buy” and put a $50.00 price target on the stock following the results. Calls are outnumbering puts roughly 4:1 with the January 15th 2021 55.00 call being the most actively traded contract (volume is 3,694)." Stock currently trading @ $41.94 - Thankfully, NP... yet
- Bwhitty: $ARCT that's a move down.
- scottrades: @Bwhitty $ARCT Man, I just don't have the stomach for biotech...lol
- Hemal: @scottrades $ARCT I look at it this way, there are so many better and low risk opportunities every single day why to buy something that can go nuts on us without warning. I am going to be spending time to see if there is a better risk/reward profile to trade/invests in biotech down the road.
- scottrades: @Hemal $ARCT I agree, I think it makes more sense to trade an ETF.
- Bwhitty: @scottrades $ARCT Agreed!
- shoredriver: $ARCT...continuing nicely long from way below...fat monthly call selling....
- Dig44north: $ARCT breakout, good volume
- shoredriver: $ARCT...added previously... up14%.....selling chub monthlies.....
- joelsg1: $ARCT Cathie Wood is killing it this year. In her genome fund $ARCT, $NTLA, $NVTA or just buy the fund $ARKG.
- shoredriver: @joelsg1 $ARCT $NTLA $NVTA $ARKG ...agree and prefer $ARKK
- joelsg1: @shoredriver $ARCT $NTLA $NVTA $ARKG $ARKK That one too, $TSLA in there big.
- shoredriver: $ARCT...trying....long around 100......
- joelsg1: $ARCT @bRobert: Pullback buy point?
- bRobert: @joelsg1 $ARCT testing $100. top of cup below and lower channel line It would be an aggressive add with stop < LOD.
- bRobert: @joelsg1 $ARCT Higher risk trade. Not for me
- joelsg1: @bRobert $ARCT You da man, Thanks.
- joelsg1: @bRobert $ARCT Will watch for a little stability around 100 first.
- rholden: $ARCT - Arcturus - announced at 4:33 PM today a proposed public offering - no details elucidated.
- joelsg1: @rholden $ARCT This is the Covid vaccine company Cathy Wood likes, self-replicating messenger rna, so like $MRNA and $PFE but only need one shot and at a much lower dose than those others, with much longer protection, perhaps lifetime. Completing Phase 2 now, so probably needs this money for Phase 3, although they may partner up. They also have other drug candidates based on their technology.Watch this one, though it has already moved big.
- gwenzee: @Champ @Herb @Rjelerik $ARCT Up another 9% today......so far. Just hit 100!!!! More Happy Dancing. Presenting at Piper Sandler 32nd Ann. Conf. at 10 am ET. Must be an invitee to attend or listen to presentation. Will probably report in their website.
- Rjeletrik: @gwenzee $ARCT way to go beautiful! Good morning. Happy Holidays!
- gwenzee: @Rjeletrik @Herb $ARCT Hope you have been watching this monster. And.....making the big bucks. Look at the chart. Doing a Happy Dance.
- gwenzee: $ARCT This baby was at $61.06 on Friday at its low. It is now at $87.15. Do the math!!! WOW Another COVID stock that is getting no coverage.
- champ: @gwenzee $ARCT --- Power move, must be News and I'm looking for the reasons Why.......hard to buy in the Dark, need light, not any light......
- gwenzee: @champ $ARCT Right now there is no news. Amazing climb. Wait until good news hits. Could we see $150??? When will the shorts decide it's time to cover?
- champ: @gwenzee $ARCT -----looks like they are in this Stock,....so I moved into $LABU......
- gwenzee: $ARCT Only up 20.74% today. :)
- debeers: @gwenzee $ARCT -you are definitely losing your touch, Gwennie!LOL
- gwenzee: @debeers $ARCT Told you to buy this one, smartie.
- gwenzee: @Champ $ARCT at Piper Sandler’s 32nd Annual Virtual Healthcare Conference: The Road Ahead for COVID-19 Vaccines: What We Know and Questions Still to be Answered into 2021 Panel Presentation Date: Tuesday, Dec 1, 2020 Time: 10:00 a.m. ET This is FYI. Just came into my email.
- champ: @gwenzee $ARCT --- #Thanks....I see that now, $ARCT is a late addition to that Conference, or I would have saw that...they announced today 11/30, for tomorrow 12/1 at 10:00 am ET, ....they will be having a Question and Answers session, is what I'm seeing, they used those words..... This company was founded in 2013 in San Diego....they could sure be on a roll-now.....
- gwenzee: @champ $ARCT #Thanks They just celebrated their 3rd anniversary on the NASDAQ. So much hinges on the Covid vaccine results. Fingers and toes are crossed. That could be a blockbuster.
- gwenzee: @Bs7518 Not bRoberts but hold several Biotech and Med device stocks. Some you might want to investigate. $NBIX $ARCT $INCY $RVNC $TNDM $SILK Please let me know if this helps.
- Bs7518: @gwenzee $NBIX $ARCT $INCY $RVNC $TNDM $SILK thank you so much i'll research
- gwenzee: @Bs7518 $NBIX $ARCT $INCY $RVNC $TNDM $SILK Make sure you check the reporting dates. Listening to the conf. calls is helpful also. TNDM reports tomorrow and the rest report next week.
- greenpatrol: $ARCT triggered an inside week and up at 55.05
- gwenzee: $AAPL $AMD $ARCT $AYX $CARR $CHGG $CYRX $DT $FAST $INCY $LVGO $MSFT $NBIX $NUAN $PFSI $RVNC $SHOP $SILK $TNDM $TDOC These are the stocks I am holding right now. Took partial profits on several yesterday. And.....today everyone of them is up. But....I rang the register. Amazing what one day can and does do to one's portfolio.
-
gwenzee: $ARCT Doji on Friday followed by a big beautiful green candle today. Best Friend pattern. Will be reporting on COVID vaccine progress later this quarter. Then.....up, up and away!!! This is not a one-trick pony.
Today reported that lipids wer ... -
gwenzee: $ARCT Under the radar biotech working on COVID vaccine.
Arcturus COVID-19 Vaccine has Significant Advantages
A R C T U R U S T H E R A P E U T I C S
Potential Single Shot
• Small, single intramuscular injection, devoid of adjuvants
• Sim ... - heyjack: @gwenzee $ARCT $cyrx Does that mean I can sell my $cyrx ?
- gwenzee: @heyjack $ARCT $cyrx At your own risk. :)
- heyjack: @gwenzee $ARCT $cyrx :)
-
gwenzee: @bRobert $ARCT Announced it is in talks with a dozen countries to supply coronavirus vaccine. Stock has 25-30% measured move upside. It has bumped its head on $60 a couple of times. Perhaps this time it can hold above???
SAN DIEGO, Aug. 11, 202 ... - Herb: @gwenzee $ARCT gracias
- Rjeletrik: @gwenzee $ARCT thank you beautiful!
- 10-penny: @gwenzee $ARCT Biotech news is like earnings news, the day of that [good} announcement it dropped 15%. :) now climbing back though trying to break through that resistance at 63
- 10-penny: @10-penny $ARCT probably a high risk buy until it breaks through on volume
- gwenzee: @10-penny $ARCT Vol. today is over 750,000 (so far) with avg. daily vol. of about 850,000. I'd say that is high vol. for this baby.
- gwenzee: @10-penny $ARCT I have made a lot of $$$ in biotech stocks over the past several years. I know what the FDA can do by their rulings....good and bad. This is one woman's opinion based upon what I know and what the chart is telling me. Time will tell whether I am blind or not.
- Herb: $ARCT best-acting Covid today. Nice daily chart.
- Sher: FYI for anyone holding vaccine developers: Non-Warp Speed COVID-19 vaccine players under pressure Jun. 3, 2020 3:29 PM ET|About: Vir Biotechnology, Inc. ($VIR)|By: Douglas W. House, SA News Editor Certain COVID-19 vaccine developers that the Trump administration left out of the final round of Operation Warp Speed are under pressure on the loss of potential federal funding to support their development efforts. Selected tickers: Vir Biotechnology ($VIR -9.5%), Novavax ($NVAX -13.6%), Dynavax ($DVAX -4.4%), Altimmune ($ALT -6.6%), BioNTech ($BNTX -1.0%), Arcturus Therapeutics ($ARCT -11.6%), Soligenix ($SNGX), GeoVax Labs (OTCPK:$GOVX -3.9%), Inovio Pharmaceuticals ($INO -12.8%), iBio (I$BIO -5.2%), Vaxart ($VXRT -6.3%)
- Jim88: @Sher $NVAX $DVAX $ALT $BNTX $ARCT $SNGX $GOVX $INO $BIO $VXRT === $BNTX is partnered with $PFE, so they are funded, but add $SRNE to the list.
- Herb: Your Corona of the Day: $ARCT. Float 9.2M
- teacher5: @Herb $ARCT Wish I had seen that one coming.
- issues: @debeers $AXSM others in this biomedical group include: $ACST (up 40% in 10 days) $GLPG (35%) $ENLV (25%) $ARCT (25%) $ARWR $ATEC. We are holding positions in AXSM ARCT ARWR ATEC...
- issues: I bought $CFMS & $ATEC and sold partial positions in $ARCT $SSO $DG $COST
- issues: A big thank you to Dana and all those who suggest REITs. I bought $LADR $MRCC today. Considering $SAR and $EARN. Also, added to GLUU. Thanks to Dan for suggesting oil, so I added to XLE and WLL. Also added to $T (again thanks to you Dan!) I sold $FL and $FDC. Dead money. Biotechs: bought these: $ARWR $SVMK $ARCT and tele: $TEUM I put $BAND on a watch list when it was $62. I kept putting it off then looked at it today. Up $10 since I first noticed it. Now it's too extended. That's a day's work for me, Whew!
| Stock Price | $17.73 |
| Change | -3.59% |
| Volume | 330,973 |
Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.
Request Video of ARCTAlready a member? Sign in here.
Past Month
Leading Peers
-
$46.80 373.26%
-
$7.45 219.45%
-
$28.44 135.31%
Past Month
Lagging Peers
-
$21.63 -48.13%
-
$9.61 -42.37%
-
$17.73 -36.26%
Dan Fitzpatrick
Stock Market Mentor gives you EVERYTHING you need to succeed in the market; all in one place. How easy is that? Dan Fitzpatrick and his elite community of traders share trading ideas, strategies and much more. Dan Fitzpatrick--a world class Technical Analyst, trading coach and regular CNBC contributor--gives you access to all of this with a 30 day trial membership for just $7.77. Get started TODAY and start trading better TOMORROW with the following premium content:
- Nightly video Strategy Sessions with a game plan for tomorrow
- Got a stock you want Dan to look at? Just ask.
- Patent pending video alerts instantly delivered to you when one of Dan’s trading signals is triggered. This is not your typical price alert. This is a short video explaining the action you need to take to make money. No more “Woulda, coulda, shoulda”
- Access to over 90,400 stock analysis videos
- Access an ever expanding library (90,400) of educational videos that will save you time and make you money
Join a team of friends and traders that have one thing in common; a burning desire to succeed.
Become a Member Today!
Gain immediate access to all our exclusive articles, features, how-to's, discussion group and much more...
Satisfaction Guaranteed!
Your Stock Market Mentor membership comes with a 30 day, no questions asked, 100% money back guarantee!